Clinical Trials Logo

Incisional Hernia clinical trials

View clinical trials related to Incisional Hernia.

Filter by:

NCT ID: NCT05094089 Recruiting - Hernia, Ventral Clinical Trials

Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application

SYN 20-01
Start date: February 24, 2023
Phase:
Study type: Observational

The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.

NCT ID: NCT05005663 Recruiting - Incisional Hernia Clinical Trials

Incisional Hernia in Infants and Children

Start date: February 2, 2007
Phase: N/A
Study type: Interventional

the study of development of incisional hernia in infants and children at a tertiary level experience.

NCT ID: NCT04982653 Recruiting - Clinical trials for Metastatic Malignant Neoplasm in the Liver

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

Start date: January 4, 2022
Phase: Phase 2
Study type: Interventional

This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an abdominal hernia) at the incision site better than the other.

NCT ID: NCT04808063 Recruiting - Clinical trials for Incisional Hernia of Midline of Abdomen

Algorithm for Prophylactic Mesh Use in Emergency Laparotomy.

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Use of informed algorithm for patients selection of prophylactic mesh aplication after midline laparotomy in emergency surgery.

NCT ID: NCT04794582 Recruiting - Clinical trials for Postoperative Complications

Prevention of Incisional Hernia After Renal Transplantation

Start date: August 31, 2022
Phase: N/A
Study type: Interventional

Randomized clinical trial to determine the efficacy of mesh reinforcement in laparotomy closure in renal transplantation as measured by reduction in the incidence of incisional hernia at 2 years post-transplantation.

NCT ID: NCT04718168 Recruiting - Incisional Hernia Clinical Trials

GORE® ENFORM Biomaterial Product Study

ENF 18-06
Start date: May 17, 2021
Phase: N/A
Study type: Interventional

A prospective, retrospective, non-randomized, multicenter study with two independent hernia study cohorts (Ventral / Incisional Hernia Repair and Diaphragmatic / Hiatal Hernia Repair). The primary objective of this study is to collect GORE® ENFORM Biomaterial product commercial-use data on device functional performance.

NCT ID: NCT04699201 Recruiting - Incisional Hernia Clinical Trials

Trocar Site Incisional Hernia Prevention

PHIT
Start date: March 2, 2021
Phase: N/A
Study type: Interventional

Objective: To test the preventive effect of the placement of an onlay mesh versus the use of a fascial closure device at the umbilical trocar site closure in order to prevent incisional hernia after laparoscopic surgery. Methods: We designed a Two Center Randomized Controlled Trial were adult participants presenting for elective laparoscopic cholecystectomy, with or without an exploration of the common bile duct will be recruited, with allocation of each of them in 2 groups (prosthesis and control). Abdominal ultrasound scan focused on aponeurosis defects at the trocar sites will be performed at 12 postoperative months. An ultrasound scan will be performed to avoid underdiagnosis bias since incisional hernia is frequently under detected by clinical examination. Relevance: The prevalence of incisional hernia after laparoscopy might be as high as 30%, due to this reason is paramount to find a better closure technique. There are few studies about incisional hernia including radiological exams in order to provide the exact prevalence of this pathology, even fewer literature exists about incisional hernia after laparoscopic procedures.

NCT ID: NCT04681326 Recruiting - Incisional Hernia Clinical Trials

Prophylactic Implantation of Biologic Mesh in Peritonitis

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Patients undergoing emergency surgery for peritonitis are at increased risk of abdominal wall-related complications. In patients with peritonitis the risk of incisional hernia (IH) is extremely elevated. The incidence of IH in patients operated with peritonitis is up to 54 %, compared with an incidence of 11-26 % in the general surgical population. Moreover, up to 24.1 % of patients with peritonitis undergoing emergency laparotomy may develop fascial dehiscence. The evaluation of quality of life of patients with IH showed lower mean scores on physical components of health-related quality of life and body image. The prophylactic mesh implantation demonstrated to reduce the incisional hernia rate in patients undergoing vascular or bariatric procedures. However, the intraperitoneal non absorbable mesh implantation in infected fields is generally considered at least of doubtful safety because of the theoretical increased risk of chronic mesh infection and enterocutaneous fistula. Most incisional hernias develop during the first three months after surgery, which represents the critical period for the healing of transected muscular and fibrous layers of the abdominal wall. However, most studies recommended a long-term follow up period of up to at least 5 years for midline abdominal incisions to determine the real incisional hernia rate. The midline abdominal incision is preferred in abdominal surgery, as it provides wide and rapid access compared other incisions. However, the incidence of incisional hernias is higher following midline abdominal incisions than in other abdominal incisions. In emergency surgery the midline incision in the majority of cases is a necessity. Several factors affect the process of wound healing: surgical site infection, poor surgical technique, and patient-related factors (i.e. peritonitis, old age, obesity, diabetes mellitus, nutritional deficiencies, hepatic cirrhosis, jaundice, renal impairment, malignancy, cardiac disease, chest problems, previous abdominal incisions, steroid therapy). Data about the use of biological prosthesis in infected fields are scarce and derive principally from case reports and case series. However, indications about their use and usefulness in infected fields have been recently published by the Italian Biological Prosthesis Working Group (IBPWG). A previously published prospective observational study evaluated the efficacy of implantation of biological prosthesis in high risk patients in order to reduce the incidence of incisional hernia. This study suggested the efficacy of this kind of prosthesis in reducing incisional hernia rate in patients with multiple risk factors. A recently published meta-analysis showed as the use of biological prosthesis in ventral hernia repair resulted in a lower infectious wound complication rate but in an similar recurrence rate. These results supports the application of biological prosthesis in high risk patients. One recent systematic review evaluated the positive effect on incisional hernia rate of the prophylactic mesh positioning in high risk patients. No randomized trials have been published since now about the use of biological prosthesis in contaminated or infected fields. The rationale of the trial is to evaluate the efficacy of the use of swine dermal collagen prosthesis implanted preperitoneally as a prophylactic procedure against incisional hernia in patients operated in urgency/emergency setting in contaminated/infected fields with peritonitis. The aim of the study is to reduce the incidence of incisional hernia from 50% to 20%.

NCT ID: NCT04597840 Recruiting - Clinical trials for Ventral Hernia Repair

Biosynthetic Absorbable Mesh vs Standard of Repair for the Surgical Treatment of Infected Incisional Hernia

COMpACT-BIO
Start date: May 25, 2021
Phase: N/A
Study type: Interventional

Incisional hernia is one of the most common complications of abdominal surgery and carries a significant burden for both patients and the economic health service. However, no consensus for the surgical treatment of incisional hernia in contaminated field is currently available. The purpose of the COMpACT-BIO study is to investigate the clinical and economic benefit of the use of biosynthetic mesh in contaminated incisional hernia repair.

NCT ID: NCT04537546 Recruiting - Obesity Clinical Trials

Prevention of Abdominal Incisional Hernia After Laparoscopic Digestive Surgery in Obese Patients (BMI>30kg/m2)

EVINOV
Start date: June 26, 2019
Phase: N/A
Study type: Interventional

The hypothesis of this study is to show that after laparoscopic digestive surgery in obese patients (BMI>30kg/m2), the wearing of an abdominal support belt is an effective treatment for the Incisional Hernia and feasible in terms of compliance, quality of life and patient satisfaction